A new industry-academic partnership between the University of Oxford and biopharmaceutical company NuCana as found that chemotherapy drug NUC-7738, derived from a Himalayan fungus, has 40 times greater potency for killing cancer cells than its parent compound. Oxford University researchers have worked in collaboration with industry leaders NuCana to assess a novel chemotherapy drug derived … Leggi tutto Chemotherapy drug NUC-7738 derived from a Himalayan fungus has 40 times greater potency for killing cancer cells than its parent compound